Stock listing
Tradegate:0K91 Quantum Biopharma Ltd. Subordinate Voting Shares Aktie
German listing (Tradegate) of Quantum Biopharma Ltd. Subordinate Voting Shares · home listing NASDAQ:QNTM
Follow Quantum Biopharma Ltd. Subordinate Voting Shares into a list and get an email when it puts out news.
Home listing price · NASDAQ:QNTM
$2.43 USD +0.02 (+0.8%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:QNTM
- Day range
- $2.41 – $2.55 USDOct 20, 2026
- Volume
- 51,171 sharesOct 20, 2026
- Market cap
- $15.62M USDAt the close on Oct 20, 2026 · price × 6.43M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:QNTM · Home | $2.43 USD | +0.02 (+0.8%) | 51,171 | $2.42 | $2.55 | $2.408 | $2.41 | Close on Oct 20, 2026 |
| Frankfurt:0K91 | €2.072 EUR | -0.03 (-1.4%) | — | €1.996 | €2.072 | €1.996 | €2.102 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:QNTM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.43 | +0.02 | +0.8% | $2.42 | $2.55 | $2.408 | 51,171 | |
| $2.41 | -0.06 | -2.4% | $2.49 | $2.55 | $2.40 | 63,279 | |
| $2.47 | -0.24 | -8.9% | $2.68 | $2.747 | $2.46 | 190,412 | |
| $2.71 | +0.05 | +1.9% | $2.65 | $2.74 | $2.60 | 107,420 | |
| $2.66 | -0.23 | -8.0% | $2.85 | $2.889 | $2.66 | 180,276 | |
| $2.89 | +0.07 | +2.5% | $2.83 | $2.97 | $2.80 | 82,829 | |
| $2.82 | -0.12 | -4.1% | $2.98 | $3.00 | $2.80 | 157,500 | |
| $2.94 | -0.17 | -5.5% | $3.11 | $3.11 | $2.94 | 129,500 | |
| $3.11 | -0.035 | -1.1% | $3.10 | $3.23 | $3.10 | 77,300 | |
| $3.145 | +0.055 | +1.8% | $3.07 | $3.16 | $3.02 | 149,400 | |
| $3.09 | -0.18 | -5.5% | $3.34 | $3.39 | $3.05 | 618,800 | |
| $3.27 | -0.17 | -4.9% | $3.40 | $3.49 | $3.25 | 245,900 | |
| $3.44 | +0.015 | +0.4% | $3.38 | $3.47 | $3.32 | 79,200 | |
| $3.425 | -0.175 | -4.9% | $3.56 | $3.663 | $3.40 | 82,700 | |
| $3.60 | -0.22 | -5.8% | $3.72 | $3.80 | $3.53 | 110,300 | |
| $3.82 | -0.14 | -3.5% | $3.95 | $3.957 | $3.707 | 119,600 | |
| $3.96 | +0.11 | +2.9% | $3.86 | $3.99 | $3.672 | 139,800 | |
| $3.85 | -0.15 | -3.7% | $4.00 | $4.00 | $3.80 | 193,400 | |
| $4.00 | +0.12 | +3.1% | $4.00 | $4.30 | $3.823 | 563,800 | |
| $3.88 | +0.18 | +4.9% | $3.65 | $4.34 | $3.65 | 643,800 | |
| $3.70 | +0.09 | +2.5% | $3.66 | $3.90 | $3.60 | 193,700 | |
| $3.61 | -0.05 | -1.4% | $3.65 | $3.82 | $3.52 | 78,600 | |
| $3.66 | -0.06 | -1.6% | $3.69 | $3.83 | $3.615 | 95,100 | |
| $3.72 | +0.07 | +1.9% | $3.63 | $3.88 | $3.63 | 191,700 | |
| $3.65 | +0.19 | +5.5% | $3.48 | $3.69 | $3.386 | 199,100 | |
| $3.46 | 0.00 | 0.0% | $3.43 | $3.50 | $3.25 | 101,500 | |
| $3.46 | +0.26 | +8.1% | $3.22 | $3.59 | $3.135 | 173,400 | |
| $3.20 | -0.09 | -2.7% | $3.32 | $3.39 | $3.20 | 200,700 | |
| $3.29 | -0.29 | -8.1% | $3.54 | $3.60 | $3.082 | 238,500 | |
| $3.58 | +0.29 | +8.8% | $3.34 | $3.739 | $3.33 | 445,400 | |
| $3.29 | +0.05 | +1.5% | $3.28 | $3.37 | $3.06 | 131,100 | |
| $3.24 | +0.29 | +9.8% | $3.01 | $3.27 | $2.99 | 110,800 | |
| $2.95 | -0.13 | -4.2% | $3.10 | $3.19 | $2.91 | 114,200 | |
| $3.08 | +0.04 | +1.3% | $3.07 | $3.14 | $3.00 | 51,400 | |
| $3.04 | -0.13 | -4.1% | $3.14 | $3.233 | $3.02 | 82,700 | |
| $3.17 | +0.095 | +3.1% | $3.02 | $3.23 | $3.02 | 81,500 | |
| $3.075 | -0.055 | -1.8% | $3.15 | $3.21 | $3.07 | 87,300 | |
| $3.13 | +0.06 | +2.0% | $3.08 | $3.24 | $3.03 | 58,300 | |
| $3.07 | -0.21 | -6.4% | $3.28 | $3.37 | $3.06 | 124,200 | |
| $3.28 | +0.04 | +1.2% | $3.36 | $3.43 | $3.12 | 143,200 | |
| $3.24 | -0.20 | -5.8% | $3.44 | $3.45 | $3.126 | 205,400 | |
| $3.44 | 0.00 | 0.0% | $3.49 | $3.58 | $3.35 | 137,600 | |
| $3.44 | -0.08 | -2.3% | $3.52 | $3.52 | $3.36 | 149,700 | |
| $3.52 | +0.18 | +5.4% | $3.61 | $3.85 | $3.27 | 280,400 | |
| $3.34 | -0.34 | -9.2% | $3.68 | $3.731 | $3.23 | 310,800 | |
| $3.68 | -0.12 | -3.2% | $3.98 | $4.20 | $3.465 | 1,223,500 | |
| $3.80 | +0.57 | +17.6% | $3.34 | $3.95 | $3.31 | 277,300 | |
| $3.23 | -0.25 | -7.2% | $3.43 | $3.47 | $3.11 | 223,300 | |
| $3.48 | -0.07 | -2.0% | $3.60 | $3.67 | $3.37 | 152,100 | |
| $3.55 | +0.09 | +2.6% | $3.52 | $3.835 | $3.47 | 475,000 | |
| $3.46 | +0.01 | +0.3% | $3.40 | $4.08 | $3.24 | 1,827,200 | |
| $3.45 | +0.22 | +6.8% | $3.29 | $3.70 | $3.22 | 181,600 | |
| $3.23 | +0.33 | +11.4% | $2.90 | $3.25 | $2.81 | 64,300 | |
| $2.90 | +0.03 | +1.0% | $2.92 | $3.00 | $2.771 | 91,200 | |
| $2.87 | -0.18 | -5.9% | $3.00 | $3.05 | $2.66 | 230,000 | |
| $3.05 | +0.16 | +5.5% | $2.96 | $3.12 | $2.88 | 44,800 | |
| $2.89 | +0.05 | +1.8% | $2.95 | $2.96 | $2.77 | 50,100 | |
| $2.84 | +0.01 | +0.4% | $2.83 | $2.98 | $2.83 | 48,200 | |
| $2.83 | -0.17 | -5.7% | $2.96 | $2.98 | $2.73 | 91,600 | |
| $3.00 | +0.03 | +1.0% | $2.97 | $3.145 | $2.90 | 48,900 | |
| $2.97 | -0.02 | -0.7% | $2.95 | $2.99 | $2.84 | 31,000 | |
| $2.99 | +0.15 | +5.3% | $2.86 | $2.99 | $2.78 | 37,300 | |
| $2.84 | -0.01 | -0.4% | $2.81 | $2.95 | $2.695 | 180,900 | |
| $2.85 | -0.17 | -5.6% | $2.96 | $3.037 | $2.82 | 84,100 | |
| $3.02 | -0.02 | -0.7% | $3.04 | $3.12 | $2.96 | 99,900 | |
| $3.04 | -0.20 | -6.2% | $3.19 | $3.27 | $2.99 | 222,400 |
- Ticker
- Tradegate:0K91
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results
Latest deck · September 2026
Quantum BioPharma — Investor Presentation (September 2026)
Investor deck · 27 slides
Latest news
Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results
Oct 20, 2026
Closed $2.43 (+0.8%) on Oct 20, 2026
Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial
Oct 7, 2026
Closed $3.15 (+1.8%) on Oct 7, 2026
Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Oct 6, 2026
Closed $3.09 (-5.5%) on Oct 6, 2026
Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
Oct 6, 2026
Closed $3.09 (-5.5%) on Oct 6, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
Sep 30, 2026
Closed $3.60 (-5.8%) on Sep 30, 2026
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
Sep 24, 2026
Closed $4.00 (+3.1%) on Sep 24, 2026
Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
Sep 17, 2026
Closed $3.72 (+1.9%) on Sep 17, 2026
Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
Sep 15, 2026
Closed $3.46 (0.0%) on Sep 15, 2026
NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating 'Rare Moment' in MS Research
Sep 14, 2026
Closed $3.46 (+8.1%) on Sep 14, 2026
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
Sep 11, 2026
Closed $3.20 (-2.7%) on Sep 11, 2026
Decks
Quantum BioPharma — Investor Presentation (September 2026)
Investor deck · 27 slides · September 2026
Quantum Biopharma Ltd. Subordinate Voting Shares on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 51 in the last 12 months · 260 in all · newest Oct 20, 2026 · oldest 2019
- Decks
- 1 deck · latest September 2026
Where Quantum Biopharma Ltd. Subordinate Voting Shares is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:QNTM · Home listing | NASDAQ | United States | USD |
| CSE:QNTM · Delisted | CSE | Canada | CAD |
| gettex:0K91 | gettex | Germany | EUR |
| LS Exchange:A2P8F1 | LS Exchange | Germany | EUR |
| Cboe Canada:QNTM | Cboe Canada | Canada | CAD |
| BOATS:QNTM | BOATS | United States | USD |
| Lang & Schwarz:A2P8F1 | Lang & Schwarz | Germany | EUR |
| Tradegate:0K91 · This page | Tradegate | Germany | EUR |
| Munich:0K91 | Munich | Germany | EUR |
| Dusseldorf:0K91 | Dusseldorf | Germany | EUR |
| Frankfurt:0K91 | Frankfurt | Germany | EUR |
| Hamburg:0K91 | Hamburg | Germany | EUR |
| Stuttgart:0K91 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Quantum Biopharma Ltd. Subordinate Voting Shares.